CVRx, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
CVRX on Nasdaq
Location
9201 West Broadway Avenue, Suite 650, Minneapolis, MN

Insiders trading volume in the past year

CVRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Johnson & Johnson Innovation - JJDC, Inc. 10%+ Owner $64.9M Sep 15, 2023
New Enterprise Associates 10 L P 10%+ Owner $37.6M Jul 2, 2021
Geoffrey B. Pardo Director $34M Jul 2, 2021
Johnson & Johnson 10%+ Owner $21.1M -$96.1K -0.45% Feb 16, 2024
GSK plc 10%+ Owner $18.7M Jul 2, 2021
Nea Partners 10 L P 10%+ Owner $3.22M Jul 2, 2021
Kevin Hykes PRES & CEO, Director $1.18M +$251K +27.1% Aug 5, 2024
Robert Allen John Chief Revenue Officer $628K Jun 27, 2024
Nadim Yared CHIEF EXECUTIVE OFFICER, Director $601K Feb 2, 2024
John Brintnall Chief Strategy Officer And Sec $585K Apr 22, 2022
Jared Oasheim Chief Financial Officer $572K Feb 2, 2024
Joseph P. Slattery Director $388K +$71.7K +22.7% Aug 15, 2024
Paul Verrastro Chief Mktg & Strat Officer $388K -$75.2K -16.2% Nov 19, 2024
Kevin J. Ballinger Director $186K Sep 3, 2024
Mitch C. Hill Director $186K Sep 3, 2024
Ali Behbahani Director $146K Jun 4, 2024
Mudit K. Jain Director $140K Jun 4, 2024
Martha Shadan Director $140K Jun 4, 2024
Kirk G. Nielsen Director $140K Jun 4, 2024
John M. Nehra Director $139K Jun 7, 2022
Ding Dean Bruhn Vp Of Reg. Affairs And Qa $30.8K Aug 2, 2022
Liz Galle Vp Of Global Clinical Research $14.4K Oct 16, 2023
Craig E. Palmer Svp, U.S. Sales $6.32K Mar 25, 2024

Recent Insider Transactions by Companies or Individuals for CVRx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.